image: In a clinical trial, lampalizumab treatment (right) prevented retinal lesion growth and eye deterioration for 18 months in patients with dry age-related macular degeneration. view more
Credit: B.L. Yaspan <i>et al., Science Translational Medicine</i> (2017)